A new study allows women with type 2 diabetes to breathe a sigh of relief – no connection has been found between the use of statins or metformin and ovarian cancer. This study was completed at Finland’s University of Oulu, and it examined over 137,000 women over the age of 40 diagnosed with type 2 diabetes in the country from 1996-2011. During the follow-up period, 303 women had been diagnosed with ovarian cancer.
Compared to other oral diabetes medications, metformin was not associated with a higher rate of ovarian cancer. Additionally, no association was noted between statins and ovarian cancer incidence.
These findings were published in BJOG: An International Journal of Obstetrics and Gynecology on February 7, 2018.